Category: Accuray Inc.Syndicate content

Silicon Valley in-depth: Tapping medtech's Big Data with AliveCor CEO Euan Thomson

May 16, 2014 by Arezu Sarvestani

AliveCor's interim-ish CEO Euan Thomson talks about the data-driven future, why he jumped ship at Accuray and how to navigate the intersection between the tempered medical device world and the wanton nimbleness of Silicon Valley.

In depth in Silicon Valley: Mobile health and medtech's digital future with AliveCor CEO Euan Thomson

When Euan Thomson left Accuray (NSDQ:ARAY) in 2012 after more than 10 years, it wasn't so much for greener pastures as it was for swifter currents.

Morgan Stanley: Medtech underperformed in April

May 5, 2014 by Brad Perriello

Medtech stocks flipped the script last month, having underperformed the S&P 500 by 4% after out-performing the index by nearly 5% during the 1st quarter, according to a Morgan Stanley analysis.

Morgan Stanley: Medtech underperformed in April

The medical device sector under-performed the S&P 500 index in April after a sharp swing over-performance during the 1st quarter, according to analysts at Morgan Stanley.

The 30 medtech stocks Morgan Stanley covers collectively under-performed the S&P by 4.1%, after besting the index by 4.9% during the 1st quarter.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Revenue surge helps Accuray narrow Q3 losses, update full-year outlook

May 2, 2014 by Arezu Sarvestani

California medtech maker Accuray boosts its full-year revenue outlook after posting Q3 2014 sales nearly 40% higher than last year.

Revenue surge helps Accuray narrow Q3 losses, update full-year outlook

Radiosurgery systems maker Accuray (NSDQ:ARAY) sees continued momentum on the horizon as a boost in Q3 sales prompts an updated, increased full-year outlook.

Accuray notches win in trade secrets row with former supplier

February 11, 2014 by Arezu Sarvestani

Radiosurgery systems maker Accuray lands summary judgment in trade secrets lawsuit filed by former supplier Rotary Systems.

Accuray notches win in trade secrets row with former supplier

California medtech maker Accuray (NSDQ:ARAY) tallied a win in a trade secrets lawsuit filed by a former supplier, announcing that a Minnesota court awarded summary judgment against Rotary Systems.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Accuray soars on Street-beating Q2 and increased guidance

January 31, 2014 by Arezu Sarvestani

Accuray slashes Q2 losses and ups its earnings expectations for the year, prompting a 13% boost from Wall Street.

Accuray soars on Street-beating Q2 and increased guidance

California radiation oncology systems maker Accuray (NSDQ:ARAY) scored major Wall Street points with its 2nd quarter financial report, with shares soaring on news of lowered losses and increased guidance for the year.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Accuray gains on Q1 results

November 8, 2013 by Brad Perriello

Accuray shares are up today after the medical device company reports reduced losses and increased profit margins.

Accuray gains on Q1 results

Accuray (NSDQ:ARAY) shares gained nearly 10% this morning after the medical device company reported lower fiscal 1st-quarter losses and an improved profit margin.

Sunnyvale, Calif.-based Accuray logged losses of $15.5 million, or -21¢ per share, on sales of $76.6 million for the 3 months ended Sept. 30, for a loss reduction of 35.6% on a sales decline of 7.4%.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp